RecallDepth
Class II Terminated

Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5

Company
Apotex Inc.
Recall Initiated
August 17, 2015
Posted
September 23, 2015
Recall Number
D-1814-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
117,644 Bottles
Firm Location
Toronto, Canada

Reason for Recall

Failed Stability Specifications: product may not meet specification limit for assay test.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #s: a) KP9749, KT3501, Exp 09/2015, KP4524, Exp 11/2015, KV8264, Exp 01/2016, KX8713, KX8714, KX8715, Exp 04/2016; b) KP4525, Exp 11/2015, KP9750, Exp 12/2015, KX8716, Exp 04/2016

More recalls by Apotex Inc.

View all recalls by this company →

Other recent Class II Drug recalls